Evidence map›Paper›PMID 39001397›Full record

ArticleCancers2024

Timing of Resection of Spinal Meningiomas and Its Influence on Quality of Life and Treatment.

Michael Schwake, Wesam Said, Marco Gallus, Emanuele Maragno, Stephanie Schipmann, Dorothee Spille, Walter Stummer, Benjamin Brokinkel

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael SchwakeDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.ORCID 0000-0003-4062-4785
Wesam SaidDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.
Marco GallusDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.
Emanuele MaragnoDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.
Stephanie SchipmannDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.
Dorothee SpilleDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.ORCID 0000-0001-8358-1848
Walter StummerDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.
Benjamin BrokinkelDepartment of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe main treatment modality for spinal meningiomas (SM) is gross total resection (GTR). However, the optimal timing of surgery, especially in cases with absent or mild neurological symptoms, remains unclear. The aim of this study is to assess the impact of early-stage resection on neurological outcome, quality of life (QoL), and quality of care. The primary objective is a favorable neurological outcome (McCormick scale 1).

methodsWe retrospectively analyzed data from patients who underwent operations for SM between 2011 and 2021. Patients with mild neurological symptoms preoperatively (McCormick scale 1 and 2) were compared to those with more severe neurological symptoms (McCormick scale 3-5). Disabilities and QoL were assessed according to validated questionnaires (SF-36, ODI, NDI).

resultsAge, spinal cord edema, thoracic localization, and spinal canal occupancy ratio were associated with more severe neurological symptoms (all

conclusionsEarly surgical intervention for SM, before the development of severe neurological deficits, should be considered as it is associated with a favorable neurological outcome and quality of life.

Indexed as

quality of carequality of lifespinal meningiomaspinal tumor

Identifiers

PMID39001397
PMCPMC11240410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.